Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group

Clinical and Translational Oncology

Volumn 9, Issue 3, 2007, Pages 183-191

  Cambray i Amenos M ^a   Navarro Garcia M ^a   Marti Rague J ^b   Pareja Fernandez L ^a   Pera Fabregas J ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Chemotherapy; Neoadjuvancy; Radiotherapy; Rectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC ANTIMETABOLITE;

ADJUVANT THERAPY; ADULT; AGED; ANUS SPHINCTER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; PROGNOSIS; PROSPECTIVE STUDY; RADIATION ENTEROPATHY; RECTUM CANCER; SURVIVAL TIME; TREATMENT RESPONSE; ADENOCARCINOMA; AMPUTATION; COLOSTOMY; KAPLAN MEIER METHOD; MORTALITY; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATHOLOGY; PELVIS EXENTERATION; PREOPERATIVE CARE; RECTUM TUMOR; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; AMPUTATION; ANTIMETABOLITES, ANTINEOPLASTIC; COLOSTOMY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUCOVORIN; MALE; NEOADJUVANT THERAPY; PALLIATIVE CARE; PELVIC EXENTERATION; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34250374902     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0033-4     Document Type: Article

References (31)

1. Pahlman L, Glimelius B (1990) Pre or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 211:187-195
2. Frykholm GJ, Glimelius B, Pahlman L (1993) Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomized trial and evaluation of late secondary effects. Dis Colon Rectum 36:564-572
3. Glimelius B, Isacsson U, Jung B et al (1997) Radiotherapy in addition to radical surgery in rectal cancer: Evidence for a dose-response effect favoring preoperative treatment. Int J Radiat Oncol Biol Phys 37:281-287
4. Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: A systematic overview of 8507 patients from 22 randomised trials. Lancet 358:1291-1304
5. Kapiteijn E, Marijnen CAM, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646
6. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731-1740
7. Cammà C, Giunta M, Fiorica F et al (2000) Preoperative radiotherapy for resectable rectal cancer. A meta-analysis. JAMA 284:1008-1015
8. Bosset JF, Horiot JC, Hamers HP et al (2001) Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol 61:7-13
9. Hyams DM, Mamounas EP, Petrelli N et al (1997) A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. A progress report of National Surgical Adjuvant Breast and Bowel Project Protocol R-03. Dis Colon Rectum 40:131-139
10. Bosset JF, Calais G, Mineur L et al (2005) Preoperative radiation (preop RT) in rectal cancer: Effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial. J Clin Oncol 23, 16S:3505.abstr
11. Bosset JF, Calais G, Mineur L et al (2005) Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. J Clin Oncol 24:5620-5627
12. Valentini V, Coco C, Picciocchi A et al (2002) Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A longterm analysis of 165 patients. Int J Radiat Oncol Biol Phys 53:664-674
13. Fernández-Martos C, Aparicio J, Bosch C et al (2004) Preoperative uracil, Tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' followup. J Clin Oncol 22:3016-3022
14. Chan AKP, Wong A, Jenken D et al (2005) Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or f ixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61:665-677
15. (1994) NCIC CTG Expanded common toxicity criteria. Revised: 12 December
16. Bosset JF, Calais G, Daban A et al (2004) Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: Assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC radiotherapy group. Eur J Cancer 40: 219-224
17. Calvo FA, Gómez-Espí M, Díaz-González JA et al (2001) Pathologic downstaging of T3-4 Nx rectal cancer after chemoradiation: 5-fluorouracil vs Tegafur. Int J Radiat Oncol Biol Phys 51:1264-1270
18. Tjandra JJ, Reading DM, McLachlan SA et al (2001) Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer. Dis Colon Rectum 44: 1113-1122
19. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2004) Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomized trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy. Radiother Oncol 72:15-24
20. Grann A, Feng C, Wong D et al (2001) Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 49:987-995
21. Crane ChH, Skibber JM, Birnbaum EH et al (2003) The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 57:84-89
22. Valentini V, Morganti AG, De Franco A et al (1999) Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma. Prognostic factors and long term outcome. Cancer 86:2612-2624
23. Beresford M, Glynne-Jones R, Richman P et al (2005) The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. Clin Oncol 17:448-455
24. Janjan NA, Khoo VS, Abbruzzese J et al (1999) Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: The MD Anderson cancer center experience. Int J Radiat Oncol Biol Phys 44:1027-1038
25. Janjan NA, Abbruzzese J, Pazdur R et al (1999) Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol 51:153-160
26. Mohiuddin M, Regine WF, John WJ et al (2000) Preoperative chemoradiation in fixed distal rectal cancer: Dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 46:883-888
27. Mohiuddin M, Hayne M, Regine WF et al (2000) Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 48:1075-1080
28. Reerink O, Verschueren RCJ, Szabo BG et al (2003) A favorable pathological stage after neoadjuvant radiochemotherapy in patients with initially irresectable rectal cancer correlates with a favourable prognosis. Eur J Cancer 39:192-195
29. Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351
30. Allee PE, Tepper JE, Gunderson LL et al (1989) Postoperative radiation therapy for incomplete resected colorectal carcinoma. Int J Radiat Oncol Biol Phys 17:1171-1176
31. Marijnen CAM, Nagtegaal ID, Kapiteijn E et al (2003) Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55:1311-1320